News and Announcements
Jardine Pharmaceuticals to launch new products in Australia and NZ
- Published January 05, 2015 10:49AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
As presented at the November 2014 Wholesale Investor Capital Expo’s in Singapore, Sydney and Melbourne, Jardine was on target for the December launch of the TGA Listed Polypill capsules in Australia and NZ.
Polypill – Joint and Polypill – Heart have hit the shelves!
The introduction of modified oak polyphenols into the marketplace begins a new era in the burgeoning field of life extension!
Quercus robur (French oak) is traditionally used in European medicine to help restore vitality in ageing. Emerging scientific evidence indicates that it is the complexed pyrogallols in the oak that are potent antioxidants and anti-inflammatories.
With our patented technology, we have managed to extract these compounds from the oak in a bioavailable and very efficacious form and combine them into capsules to help relieve some of the symptoms of ageing. The prebiotic effect of this unique extract may help to maintain metabolic health.
POLYPILL – JOINT:
Formulated to provide the temporary relief of the pain of osteoarthritis and help reduce joint inflammation associated with arthritis.
POLYPILL – HEART:
Formulated to help maintain metabolic health, to assist in blood lipid balance and the maintenance of normal blood pressure in healthy individuals.